Lisata Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -45 | -46 | -47 | |
EBITDA | -5,294 | -5,478 | -6,555 | -5,978 |
EBIT | -5,336 | -5,523 | -6,601 | -6,025 |
Net Income | -4,930 | -5,044 | -5,401 | -5,365 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,518 | -5,283 | -7,027 | -4,069 |
Cash | 19,509 | 28,293 | 21,805 | 22,593 |
Basic Shares | 8,321 | 8,308 | 8,294 | 8,140 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $121,372 | $0 | $0 |
Gross Profit | -189 | 63,771 | -55 | -63 |
EBITDA | -25,519 | -115,202 | -28,995 | -19,082 |
EBIT | -25,708 | -115,271 | -29,050 | -19,145 |
Net Income | -20,840 | -54,225 | -27,466 | -8,141 |
Net Change In Cash | 0 | 121,372 | 0 | 0 |
Free Cash Flow | -20,032 | -21,455 | -22,305 | -8,843 |
Cash | 22,593 | 32,154 | 24,647 | 16,512 |
Basic Shares | 8,073 | 5,180 | 3,687 | 1,029 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.59 |
2024-06-30 | -$0.61 |
2024-03-31 | -$0.65 |
2023-12-31 | -$0.66 |
